Coverage guide
Medicare GLP-1 Bridge Program Questions
CMS describes the Medicare GLP-1 Bridge as a short-term demonstration operating from July 1, 2026, through December 31, 2027. Eligible GLP-1 drugs furnished under the Bridge are provided outside the ordinary Part D benefit payment flow and coverage.
CMS beneficiary guidance says an eligible beneficiary must have a medical provider submit a prior authorization request and prescription for an eligible GLP-1 drug for a use covered under the demonstration. CMS also says beneficiaries prescribed an eligible GLP-1 drug for a use coverable under the basic Part D benefit do not qualify for that drug through the Bridge.
Use local resources to prepare for the conversation: a prescriber for medical documentation, a pharmacy for fill and network questions, a plan representative for Part D rules, and SHIP or benefits counseling for help understanding plan documents.
What to check next
Confirm the exact medication, diagnosis, formulary tier, prior authorization requirement, step therapy status, and pharmacy network before relying on a listing.
Useful documents
Plan formularies, Evidence of Coverage documents, pharmacy directories, and written prior-authorization criteria are more reliable than verbal summaries alone.